Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods
- PMID: 38019166
- PMCID: PMC10739614
- DOI: 10.1021/acschemneuro.3c00618
Techniques for Measurement of Serotonin: Implications in Neuropsychiatric Disorders and Advances in Absolute Value Recording Methods
Abstract
Serotonin (5-HT) is a monoamine neurotransmitter in the peripheral, enteric, and central nervous systems (CNS). Within the CNS, serotonin is principally involved in mood regulation and reward-seeking behaviors. It is a critical regulator in CNS pathologies such as major depressive disorder, addiction, and schizophrenia. Consequently, in vivo serotonin measurements within the CNS have emerged as one of many promising approaches to investigating the pathogenesis, progression, and treatment of these and other neuropsychiatric conditions. These techniques vary in methods, ranging from analyte sampling with microdialysis to voltammetry. Provided this diversity in approach, inherent differences between techniques are inevitable. These include biosensor size, temporal/spatial resolution, and absolute value measurement capabilities, all of which must be considered to fit the prospective researcher's needs. In this review, we summarize currently available methods for the measurement of serotonin, including novel voltammetric absolute value measurement techniques. We also detail serotonin's role in various neuropsychiatric conditions, highlighting the role of phasic and tonic serotonergic neuronal firing within each where relevant. Lastly, we briefly review the present clinical application of these techniques and discuss the potential of a closed-loop monitoring and neuromodulation system utilizing deep brain stimulation (DBS).
Keywords: FSCAV; FSCV; MDD; N-MCSWV; Serotonin; addiction; depression; electrochemistry; opioids; schizophrenia.
Conflict of interest statement
The authors declare the following competing financial interest(s): The investigators associated with this project and Mayo Clinic have a financial conflict of interest in technology used in the research in that the investigators and Mayo Clinic may stand to gain financially from the successful outcome of the research.
Figures


Similar articles
-
Advances in neurochemical measurements: A review of biomarkers and devices for the development of closed-loop deep brain stimulation systems.Rev Anal Chem. 2020;39(1):188-199. doi: 10.1515/revac-2020-0117. Epub 2020 Dec 31. Rev Anal Chem. 2020. PMID: 33883813 Free PMC article.
-
[Hepatitis C, interferon a and depression: main physiopathologic hypothesis].Encephale. 2005 May-Jun;31(3):349-57. doi: 10.1016/s0013-7006(05)82400-5. Encephale. 2005. PMID: 16142050 Review. French.
-
Simultaneous Estimation of Tonic Dopamine and Serotonin with High Temporal Resolution In Vitro Using Deep Learning.Annu Int Conf IEEE Eng Med Biol Soc. 2023 Jul;2023:1-4. doi: 10.1109/EMBC40787.2023.10341045. Annu Int Conf IEEE Eng Med Biol Soc. 2023. PMID: 38083281
-
Tonic Serotonin Measurements In Vivo Using N-Shaped Multiple Cyclic Square Wave Voltammetry.Anal Chem. 2021 Dec 28;93(51):16987-16994. doi: 10.1021/acs.analchem.1c02131. Epub 2021 Dec 2. Anal Chem. 2021. PMID: 34855368 Free PMC article.
-
Revisiting the Serotonin Hypothesis: Implications for Major Depressive Disorders.Mol Neurobiol. 2016 Jul;53(5):2778-2786. doi: 10.1007/s12035-015-9152-z. Epub 2015 Apr 1. Mol Neurobiol. 2016. PMID: 25823514 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources